
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MXC | Sydney | AUD | Delayed | |
MGCLF | OTC Markets | USD | Delayed | |
MXCM | London | GBP | Real-time |
MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. The company also provides ArtemiC range of products and cannabinoid products, as well as non-pharma products. In addition, it offers consulting services, including clinical research services. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is based in Subiaco, Australia.
Name | Age | Since | Title |
---|---|---|---|
Roby Reuven Zomer | 43 | 2016 | Co-Founder, CEO, MD & Executive Director |
Uri Kramer | - | 2016 | Member of Strategic Advisory Board |
Stephen Barry Parker | 65 | 2019 | Senior Independent Director & Interim Non-Executive Chair |
Wendyl D’Souza | - | 2018 | Member of Medical Advisory Board |
Layton Patrick Mills | - | 2023 | Non-Executive Director |
Ross Grant Thomas Walker | - | 2016 | Chairman of Strategic Advisory Board & Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review